Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Research in Pharmacogenomics and Accurate Medication of Risperidone

NCT03302364 is registered in ClinicalTrials.gov with Cui Yimin as lead sponsor.

NCT NCT03302364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03302364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Research in Pharmacogenomics and Accurate Medication of Risperidone
Lead sponsor
Cui Yimin
Phase
Observational
Overall status
Unknown status
Start date
October 22, 2017
Completion date
June 30, 2020
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mental illness, schizophrenia